Treatment of Bulimia Nervosa in a Primary Care Setting
Status:
Completed
Trial end date:
2001-12-01
Target enrollment:
Participant gender:
Summary
Bulimia Nervosa is a frequent problem for young women. It is widely assumed that this
disorder cannot be treated effectively in a primary care setting. This assumption has never
been tested empirically, and is probably incorrect.
In the last 15 years, effective treatment interventions for Bulimia Nervosa have been
developed and validated in specialized treatment centers. The broad aim of this proposal is
to examine whether these treatments, suitably adapted, can be usefully transferred to general
health care settings. Specifically, the proposed study will determine the relative and
combined effectiveness of the two leading treatments for Bulimia Nervosa in a primary care
setting. The two major interventions are treatment with an antidepressant medication,
fluoxetine, and with a form of cognitive behavioral therapy, guided self-help, designed for
use in primary care.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)